Desai AA - Search Results

1

UGT pharmacogenomics: implications for cancer risk and cancer therapeutics.

Desai AA, Innocenti F, Ratain MJ. Desai AA, et al. Pharmacogenetics. 2003 Aug;13(8):517-23. doi: 10.1097/01.fpc.0000054116.14659.e5. Pharmacogenetics. 2003. PMID: 12893990

2

Vascular endothelial growth factor pathway.

Maitland ML, Lou XJ, Ramirez J, Desai AA, Berlin DS, McLeod HL, Weichselbaum RR, Ratain MJ, Altman RB, Klein TE. Maitland ML, et al. Among authors: desai aa. Pharmacogenet Genomics. 2010 May;20(5):346-9. doi: 10.1097/FPC.0b013e3283364ed7. Pharmacogenet Genomics. 2010. PMID: 20124951 Free PMC article. Review. No abstract available.

3

Pharmacogenomics: road to anticancer therapeutics nirvana?

Desai AA, Innocenti F, Ratain MJ. Desai AA, et al. Oncogene. 2003 Sep 29;22(42):6621-8. doi: 10.1038/sj.onc.1206958. Oncogene. 2003. PMID: 14528287

4

Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes.

Innocenti F, Liu W, Chen P, Desai AA, Das S, Ratain MJ. Innocenti F, et al. Among authors: desai aa. Pharmacogenet Genomics. 2005 May;15(5):295-301. doi: 10.1097/01213011-200505000-00004. Pharmacogenet Genomics. 2005. PMID: 15864130

5

Lack of association between common polymorphisms in UGT1A9 and gene expression and activity.

Ramírez J, Liu W, Mirkov S, Desai AA, Chen P, Das S, Innocenti F, Ratain MJ. Ramírez J, et al. Among authors: desai aa. Drug Metab Dispos. 2007 Dec;35(12):2149-53. doi: 10.1124/dmd.107.015446. Epub 2007 Aug 30. Drug Metab Dispos. 2007. PMID: 17761781

6

A phase I trial of pharmacokinetic modulation of carboxyamidotriazole (CAI) with ketoconazole in patients with advanced cancer.

Desai AA, Innocenti F, Janisch L, DeMario M, Shepard D, Ramirez J, Fleming GF, Ratain MJ. Desai AA, et al. Cancer Chemother Pharmacol. 2004 Nov;54(5):377-84. doi: 10.1007/s00280-004-0841-y. Epub 2004 Jul 3. Cancer Chemother Pharmacol. 2004. PMID: 15235824 Clinical Trial.

7

A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.

Liu W, Innocenti F, Wu MH, Desai AA, Dolan ME, Cook EH Jr, Ratain MJ. Liu W, et al. Among authors: desai aa. Cancer Res. 2005 Jan 1;65(1):46-53. Cancer Res. 2005. PMID: 15665278

8

EGFR pharmacogenomics: the story continues to mutate and evolve.

Desai AA, Ratain MJ. Desai AA, et al. Am J Pharmacogenomics. 2005;5(2):137-9. doi: 10.2165/00129785-200505020-00007. Am J Pharmacogenomics. 2005. PMID: 15813677 No abstract available.

9

A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors.

Desai AA, Schilsky RL, Young A, Janisch L, Stadler WM, Vogelzang NJ, Cadden S, Wright JA, Ratain MJ. Desai AA, et al. Ann Oncol. 2005 Jun;16(6):958-65. doi: 10.1093/annonc/mdi178. Epub 2005 Apr 11. Ann Oncol. 2005. PMID: 15824081 Free article. Clinical Trial.

10

Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.

Desai AA, Kindler HL, Taber D, Agamah E, Mani S, Wade-Oliver K, Ratain MJ, Vokes EE. Desai AA, et al. Cancer Chemother Pharmacol. 2005 Oct;56(4):421-6. doi: 10.1007/s00280-005-1020-5. Epub 2005 May 13. Cancer Chemother Pharmacol. 2005. PMID: 15895230 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters